Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro InhibitorsDale J. Calleja, David Komander, Nathan W. Kuchel et al.|Frontiers in Chemistry|2022Cited by 48
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M. Bader, David Komander, Dale J. Calleja et al.|Nature Communications|2025Cited by 35
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N. Hodder, Alan F. Cowman, Janni Christensen et al.|Structure|2022Cited by 32
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Alan F. Cowman, Wendy Bailey et al.|EBioMedicine|2025Cited by 6
Molecular Modeling Studies, Synthesis and Biological Evaluation of Novel Plasmodium falciparum Lactate Dehydrogenase (pfLDH) InhibitorsPremlata Ambre, Evans C. Coutinho, Raghuvir R. S. Pissurlenkar et al.|Anti-Infective Agents|2012Cited by 2